• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

切除的非小细胞肺癌术后放疗:永无休止的故事。

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story.

作者信息

Serrano Javier, Crespo Patricia Calvo, Taboada Begoña, Gonzalez Ana Alvarez, García Rafael Garcia, Caamaño Antonio Gomez, Reyes Juan Carlos Trujillo, Mielgo-Rubio Xabier, Couñago Felipe

机构信息

Department of Radiation Therapy, Clinica Universidad de Navarra, Madrid 28027, Spain.

Department of Radiation Oncology, Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela 15706, Spain.

出版信息

World J Clin Oncol. 2021 Oct 24;12(10):833-844. doi: 10.5306/wjco.v12.i10.833.

DOI:10.5306/wjco.v12.i10.833
PMID:34733608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546654/
Abstract

This manuscript collects in a joint and orderly manner the existing evidence at the present time about postoperative treatment with radiotherapy in non-small cell lung cancer. It also systematically reviews the current evidence, the international recommendations in the most relevant guidelines, the most controversial aspects in clinical and pathological staging, the specific technical aspects of radiotherapy treatment, and also collects all the potential risk factors that have been postulated as significant in the prognosis of these patients, evaluating the possibility of segmenting a particularly sensitive subpopulation with a high risk of relapse on which an adjuvant treatment with radiotherapy could have an impact on their clinical evolution. Finally, currently active trials that aspire to provide more evidence on this topic are reviewed.

摘要

本手稿以联合且有序的方式收集了目前关于非小细胞肺癌术后放疗治疗的现有证据。它还系统地回顾了当前证据、最相关指南中的国际建议、临床和病理分期中最具争议的方面、放射治疗的具体技术方面,并且收集了所有被假定对这些患者预后有重大影响的潜在风险因素,评估了划分出一个具有高复发风险的特别敏感亚群的可能性,针对该亚群进行放疗辅助治疗可能会对其临床病程产生影响。最后,对目前正在进行的旨在提供更多关于该主题证据的试验进行了综述。

相似文献

1
Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story.切除的非小细胞肺癌术后放疗:永无休止的故事。
World J Clin Oncol. 2021 Oct 24;12(10):833-844. doi: 10.5306/wjco.v12.i10.833.
2
Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.完全切除术后II期或IIIA期非小细胞肺癌的辅助放疗和化疗。省级肺癌疾病部位组。
Cancer Prev Control. 1997 Dec;1(5):366-78.
3
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.II期或IIIA期完全切除的非小细胞肺癌术后放疗:一项系统评价与实践指南
Lung Cancer. 2004 Apr;44(1):1-11. doi: 10.1016/j.lungcan.2003.09.020.
4
The future of adjuvant chemotherapy for resected non-small cell lung cancer.可切除非小细胞肺癌辅助化疗的未来
Expert Rev Anticancer Ther. 2005 Feb;5(1):165-75. doi: 10.1586/14737140.5.1.165.
5
Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?ⅢA/B期非小细胞肺癌术后无法接受辅助化疗患者的分析:他们会从纵隔放疗中获益吗?
Thorac Cardiovasc Surg. 2016 Sep;64(6):501-6. doi: 10.1055/s-0035-1562940. Epub 2015 Aug 31.
6
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.术后放疗在可切除非小细胞肺癌中的作用:基于新数据的再评估。
Oncologist. 2011;16(5):672-81. doi: 10.1634/theoncologist.2010-0150. Epub 2011 Mar 4.
7
Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).肺癌研究肿瘤学组(西班牙放射肿瘤学会)关于肺癌术后放疗的循证推荐。
Clin Transl Oncol. 2016 Apr;18(4):331-41. doi: 10.1007/s12094-015-1374-z. Epub 2015 Aug 18.
8
Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.完全切除的早期非小细胞肺癌的术后辅助治疗。
Int J Clin Oncol. 2005 Jun;10(3):157-64. doi: 10.1007/s10147-005-0493-x.
9
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.
10
Adjuvant therapy of resected non-small-cell lung cancer.切除的非小细胞肺癌的辅助治疗
Clin Lung Cancer. 2004 Nov;6(3):162-9. doi: 10.3816/CLC.2004.n.029.

引用本文的文献

1
Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature).肺癌——流行病学、发病机制、治疗及分子层面(文献综述)
Int J Mol Sci. 2025 Feb 26;26(5):2049. doi: 10.3390/ijms26052049.
2
Factors Contributing to Postoperative Radiotherapy Delays in Head and Neck Cancer: A Comprehensive Review.头颈部癌术后放疗延迟的相关因素:一项综述
Cureus. 2024 Aug 19;16(8):e67240. doi: 10.7759/cureus.67240. eCollection 2024 Aug.
3
What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.N2 淋巴结受累对非小细胞肺癌(NSCLC)患者意味着什么?——对诊断和治疗影响的综述
Cancers (Basel). 2024 Jul 26;16(15):2673. doi: 10.3390/cancers16152673.
4
Mathematical Modeling Support for Lung Cancer Therapy-A Short Review.肺癌治疗的数学建模支持——简要综述。
Int J Mol Sci. 2023 Sep 25;24(19):14516. doi: 10.3390/ijms241914516.

本文引用的文献

1
Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.单机构应用质子和光子放疗治疗非小细胞肺癌的经验
Clin Lung Cancer. 2021 Sep;22(5):e745-e755. doi: 10.1016/j.cllc.2021.02.002. Epub 2021 Feb 7.
2
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.NCCN 指南解读:非小细胞肺癌,第 2.2021 版。
J Natl Compr Canc Netw. 2021 Mar 2;19(3):254-266. doi: 10.6004/jnccn.2021.0013.
3
The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.淋巴结比率可预测阳性淋巴结非小细胞肺癌患者的癌症特异性生存:基于人群的 SEER 分析。
J Cardiothorac Surg. 2021 Jan 19;16(1):13. doi: 10.1186/s13019-020-01390-x.
4
Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.非小细胞肺癌全肺切除术后放疗患者放射性肺炎预测因素的研究。
Cancer Radiother. 2021 Jun;25(4):323-329. doi: 10.1016/j.canrad.2020.11.001. Epub 2021 Jan 11.
5
A biomarker-based prediction model for risk of locoregional recurrence in pathologic stage IIIA-N2 non-small cell lung cancer.基于生物标志物的ⅢA-N2期非小细胞肺癌局部区域复发风险预测模型
Int J Clin Exp Pathol. 2020 Dec 1;13(12):3060-3082. eCollection 2020.
6
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy.临床和剂量学预测因素在非小细胞肺癌术后放疗患者中的放射性肺炎。
Pract Radiat Oncol. 2021 Jan-Feb;11(1):e52-e62. doi: 10.1016/j.prro.2020.09.014. Epub 2020 Oct 14.
7
Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.18F-氟脱氧葡萄糖正电子发射断层扫描或正电子发射断层扫描/计算机断层扫描对非小细胞肺癌隐匿性淋巴结转移评估的预测价值。
Oncology. 2021;99(2):96-104. doi: 10.1159/000509988. Epub 2020 Sep 25.
8
Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.淋巴结清扫数目预测非小细胞肺癌切除术后的生存。
Lung. 2020 Oct;198(5):839-846. doi: 10.1007/s00408-020-00378-7. Epub 2020 Jul 18.
9
Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.术后放疗对 IIIA 期可切除非小细胞肺癌患者生存的影响:SEER 数据库分析。
J Natl Compr Canc Netw. 2020 Jun;18(6):718-727. doi: 10.6004/jnccn.2020.7537.
10
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.COVID-19 大流行期间肺癌放疗的实践建议:ESTRO-ASTRO 共识声明。
Radiother Oncol. 2020 May;146:223-229. doi: 10.1016/j.radonc.2020.04.001. Epub 2020 Apr 6.